Delivery Order SPE2DR25D9102-SPE2DR26FDDP5
- Not listed
- The Defense Logistics Agency awarded a firm fixed-price delivery order valued at $18,474.02 to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler headquartered in Park Ridge, Illinois, for the supply of Trikafta 50-25-37.5 mg/75 mg tablets (84 count). This delivery order, issued November 4, 2025, with an ultimate completion date of November 5, 2025, was awarded without a set-aside designation, demonstrating the contractor's competitive capability in...
- The Defense Logistics Agency awarded a delivery order valued at $18,488.12 to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler headquartered in Park Ridge, Illinois, for the supply of Trikafta 100-50-75 mg/150 mg tablets (84-count units). Issued on November 6, 2025, with an ultimate completion date of November 7, 2025, this firm fixed-price delivery order carries no set-aside designation, demonstrating the contractor's competitive capability in unrestricted...
- The Defense Logistics Agency awarded a delivery order valued at $38,633.14 to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, for the supply of Trikafta 100-50-75 mg tablets in quantities of 14 packets. The delivery order, issued on October 23, 2025, with an ultimate completion date of October 24, 2025, operates under a firm fixed-price structure with no set-aside designation. This award represents a single transaction within...
- The Defense Logistics Agency awarded a $36,976.24 firm fixed-price delivery order to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, for the supply of Trikafta 100-50-75 mg/150 mg tablets (84-count unit dose packaging). The delivery order, issued on November 5, 2025, with an ultimate completion date of November 6, 2025, carries no set-aside designation, indicating the award was made through full and open competition. DMS...
- The Defense Logistics Agency awarded a delivery order valued at $18,488.12 to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, for the supply of Trikafta 100-50-75 mg/150 mg tablets. This firm fixed-price delivery order, issued on October 29, 2025, with an ultimate completion date of October 30, 2025, carries no set-aside designation, indicating the vendor competed in unrestricted federal procurement. DMS Pharmaceutical Group...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $36,976.24 to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, for the supply of Trikafta 100-50-75 mg/150 mg tablets (84-count units). This firm fixed-price delivery order, issued on October 27, 2025, was awarded without set-aside designation, demonstrating the contractor's competitive capability in unrestricted federal procurement. The delivery order falls...
- On June 10, 2025, the Defense Logistics Agency awarded a delivery order valued at $18,488.12 to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The delivery order, issued under contract number 4568543720, is for the supply of Trikafta 100-50-75 mg/150 mg tablets in a quantity of 84 units. DMS Pharmaceutical Group was selected through a firm fixed-price contract mechanism with no set-aside designation, allowing the company to...
- The Defense Logistics Agency awarded a $55,450.26 firm fixed-price delivery order to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler headquartered in Park Ridge, Illinois, for the supply of Trikafta 100-50-75 mg/150 mg tablets (84-count units). This delivery order, issued on October 21, 2025, with an ultimate completion date of October 22, 2025, was awarded without set-aside designation, reflecting the contractor's competitive capability in unrestricted...
- The Defense Logistics Agency (DLA) awarded a delivery order to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler, for $18,488.12 on August 21, 2025. The order, valued at $18,488.12 with a firm fixed-price contract type, covers the supply of Trikafta 100-50-75 mg/150 mg capsules (84 count) to be delivered to Park Ridge, Illinois by August 22, 2025. This award was issued without a set-aside designation, enabling DMS Pharmaceutical Group to compete on an open...
- The Defense Logistics Agency awarded a firm fixed-price delivery order valued at $19,316.57 to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The delivery order, issued on April 24, 2025, with an ultimate completion date of April 25, 2025, calls for the supply of Trikafta 100-50-75 mg/75 mg packets in quantities of 14. This award was issued without a set-aside designation, allowing the vendor to compete on an open basis...
- SPE2DR25D9102Indefinite Delivery Contract
- SPE2DR25D9102-SPE2DR26FDDP5Delivery Order
The Defense Logistics Agency awarded a delivery order valued at $18,868.32 to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler headquartered in Park Ridge, Illinois, for the supply of Trikafta 100-50-75 mg/150 mg tablets. The contract, issued on November 6, 2025, with an ultimate completion date of November 7, 2025, operates under a firm fixed-price structure with no set-aside designation. This delivery order represents one of numerous purchase orders issued to DMS Pharmaceutical Group by the Defense Logistics Agency's Medical Supply Chain division, demonstrating the contractor's competitive capability in unrestricted federal pharmaceutical procurement. This delivery order is issued under DMS Pharmaceutical Group's broader Indefinite Delivery Contract (IDC) designated SPE2DR within the Defense Logistics Agency's Pharmaceutical Prime Vendor Global Program Generation V (PPV-G GEN V) initiative. The parent contract, awarded on November 13, 2025, carries a ceiling value of $499.999 billion with a completion date of December 31, 2036, and authorizes the Defense Logistics Agency to issue firm fixed-price delivery orders for a comprehensive range of pharmaceutical products including branded and generic prescription drugs, biologics, and medical consumables to support military healthcare facilities worldwide. DMS Pharmaceutical Group serves as one of multiple regional prime vendor contractors under this $30.3 billion acquisition strategy, positioning the company as a critical supplier for Department of Defense healthcare operations globally.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $18.9k | 11/6/25 |